DuPont Q3 2026 Earnings: Organic Growth and Margin Expansion Lift Results

DuPont (NYSE: DD) reported Q3 2026 net sales of $1.868 billion, up 4% year over year, while diluted GAAP EPS from continuing operations rose to $1.24 from $0.70. Adjusted EPS increased 62% to $2.09, and operating EBITDA grew 8% as organic sales growth and productivity supported higher margins. Operating cash flow from continuing operations reached $410 million, while DuPont raised its full-year 2026 outlook.

Core Earnings Data

For the quarter ended September 30, 2026, organic sales increased 5%, one percentage point faster than reported sales because of a 1% currency headwind. Profit growth outpaced revenue growth, with operating EBITDA margin expanding 80 basis points to 25.1%.

GAAP income from continuing operations benefited from higher segment earnings, lower interest expense, and lower transaction costs. Adjusted EPS also benefited from lower net interest expense, a lower adjusted tax rate, and a reduced share count.

The results are presented primarily on a continuing-operations basis. DuPont’s former Electronics Business, separated as Qnity in November 2025, and the Aramids business sold in April 2026 are classified as discontinued operations. Per-share figures also reflect the 1-for-3 reverse stock split completed in June 2026.

Business and Segment Performance

Both operating segments delivered 4% reported sales growth, but Diversified Industrials posted the larger improvement in EBITDA and margin. Corporate operating EBITDA was negative $36 million, compared with negative $29 million a year earlier, partially offsetting the segment gains.

Healthcare Technologies generated mid-single-digit organic growth, led by personal protection and medical packaging. Water Technologies grew at a low-single-digit organic rate as demand from industrial water, semiconductor, and specialty markets offset continued disruption in the Middle East.

Within Diversified Industrials, Building Technologies recorded mid-single-digit organic growth due to gains in North America and Asia. Industrial Technologies also grew at a mid-single-digit rate, supported by aerospace and electric-vehicle battery applications.

The year-over-year comparisons included an additional hurdle: each segment’s Q3 2025 sales benefited by $15 million, or about 2%, from orders shifted forward from Q4 2025 because of separation-related activities.

EPS Growth Far Outpaced Sales as Financing and Transaction Costs Fell

DuPont’s 4% revenue increase translated into 8% operating EBITDA growth and substantially faster EPS growth. Organic expansion and productivity lifted segment earnings, while several non-operating and transaction-related items also improved.

Interest expense fell to $40 million from $85 million, and acquisition, integration, and separation costs declined to $15 million from $62 million. Restructuring and asset-related charges also decreased to $6 million from $18 million. Meanwhile, diluted weighted-average shares declined to 135.1 million from 140.0 million, supporting per-share growth.

The GAAP tax comparison was less favorable. DuPont recorded a $108 million provision for income taxes on continuing operations, versus an $11 million benefit in Q3 2025. Q3 2026 significant items included a $43 million tax charge, primarily related to the research-and-development expensing election and nondeductible items. Even with that pressure, pretax income from continuing operations rose to $279 million from $91 million.

Profitability, Cash Flow, and Balance Sheet

Operating cash flow from continuing operations increased 27% to $410 million. After $71 million of capital expenditures, adjusted free cash flow was $339 million, up about 37% from $248 million in the prior-year quarter.

Transaction-adjusted free cash flow nevertheless declined 1% to $341 million because DuPont added back only $2 million of separation-related payments in Q3 2026, compared with $98 million a year earlier. Transaction-adjusted free cash flow conversion was 121%, down from 192%, while adjusted free cash flow conversion was 120% versus 138%.

At September 30, 2026, cash and cash equivalents were $1.652 billion, compared with $715 million at the end of 2025. Long-term debt decreased to $3.094 billion from $3.134 billion. The nine-month cash flow statement included $1.159 billion of proceeds and adjustments from business sales, mainly associated with the Aramids divestiture.

DuPont completed a $250 million accelerated share purchase and substantially completed $100 million of open-market repurchases during the quarter. It also announced its intention to repurchase another $250 million of shares in Q4 2026.

2026 Guidance

DuPont raised its full-year 2026 outlook. Management said the new organic growth, operating EBITDA, and adjusted EPS targets were at or above the high end of its previously communicated guidance, although the release did not provide the prior numerical ranges.

Operating EBITDA and adjusted EPS guidance are non-GAAP measures. DuPont did not provide forward-looking GAAP reconciliations because it said the effects of portfolio changes, litigation, environmental matters, impairments, and discrete tax items could not be predicted with reasonable certainty.

Management Commentary

CEO Lori Koch attributed the quarter to mid-single-digit organic growth, operating leverage, and disciplined capital allocation. She also highlighted the 121% transaction-adjusted free cash flow conversion as evidence of earnings-to-cash conversion.

CFO Antonella Franzen pointed to continued strength in healthcare, aerospace, and industrial water markets. Management’s raised outlook reflects its expectation that business growth, cash generation, and productivity will continue through the end of 2026.

Risks Investors Should Monitor

• Currency pressure: Foreign exchange reduced reported Q3 sales growth by one percentage point and could continue to create a gap between organic and reported results.
• Regional disruption: Middle East disruption continued to offset part of the growth in Water Technologies, creating uncertainty around that business’s reported sales trajectory.
• Portfolio-transition execution: The Qnity separation and Aramids divestiture leave DuPont with transition-service arrangements, reimbursable indirect costs, and potential disputes or unanticipated expenses that may affect comparability and cash flow.
• Legal, environmental, and tax costs: Q3 significant items included $7 million of pretax legal costs related to Corian Quartz personal-injury cases, $4 million of corporate remediation costs, and a $43 million tax charge. Further costs could add volatility to GAAP earnings and cash flow.
• Delivery of the raised outlook: The updated guidance depends on continued growth in the healthcare, aerospace, industrial water, construction, and electric-vehicle battery markets, together with further productivity benefits.

Summary

DuPont’s Q3 2026 results combined 5% organic sales growth with productivity, lower interest expense, reduced transaction costs, and a smaller share count, allowing earnings to grow much faster than revenue. Both operating segments expanded margins, while operating cash flow improved despite transaction-adjusted free cash flow remaining nearly flat because prior-year separation-related add-backs were much larger. The main issues to monitor are execution against the raised full-year outlook, continued end-market demand, currency pressure, and costs associated with portfolio transitions and legal or environmental obligations.